CFTR: cystic fibrosis and beyond

Cystic fibrosis (CF) remains the most common fatal hereditary lung disease. The discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene 25 years ago set the stage for: 1) unravelling the molecular and cellular basis of CF lung disease; 2) the generation of animal models to s...

Full description

Saved in:
Bibliographic Details
Main Authors: Mall, Marcus A. (Author) , Hartl, Dominik (Author)
Format: Article (Journal)
Language:English
Published: June 12, 2014
In: The European respiratory journal
Year: 2014, Volume: 44, Issue: 4, Pages: 1042-1054
ISSN:1399-3003
DOI:10.1183/09031936.00228013
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1183/09031936.00228013
Verlag, lizenzpflichtig, Volltext: https://erj.ersjournals.com/content/44/4/1042
Get full text
Author Notes:Marcus A. Mall and Dominik Hartl
Description
Summary:Cystic fibrosis (CF) remains the most common fatal hereditary lung disease. The discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene 25 years ago set the stage for: 1) unravelling the molecular and cellular basis of CF lung disease; 2) the generation of animal models to study in vivo pathogenesis; and 3) the development of mutation-specific therapies that are now becoming available for a subgroup of patients with CF. This article highlights major advances in our understanding of how CFTR dysfunction causes chronic mucus obstruction, neutrophilic inflammation and bacterial infection in CF airways. Furthermore, we focus on recent breakthroughs and remaining challenges of novel therapies targeting the basic CF defect, and discuss the next steps to be taken to make disease-modifying therapies available to a larger group of patients with CF, including those carrying the most common mutation ΔF508-CFTR. Finally, we will summarise emerging evidence indicating that acquired CFTR dysfunction may be implicated in the pathogenesis of chronic obstructive pulmonary disease, suggesting that lessons learned from CF may be applicable to common airway diseases associated with mucus plugging. - Tweetable abstract ERSpublications - click to tweetCFTR dysfunction causes CF and may be implicated in more common chronic obstructive lung diseases, such as COPD http://ow.ly/wplhu
Item Description:Gesehen am 21.07.2020
Physical Description:Online Resource
ISSN:1399-3003
DOI:10.1183/09031936.00228013